You are here

Article Text

Article menu
Download PDFPDF
Cervical Cancer
High-Risk HPV Genotyping in the Follow-Up of Women Treated Conservatively for Microinvasive Cervical Cancer
  1. Mary Cairns, MBChB*,
  2. Kate S. Cuschieri, PhD†,
  3. Heather A. Cubie, PhD† and
  4. Margaret E. Cruickshank, MD*
  1. *Department of Gynaecological Oncology, Aberdeen Royal Infirmary, Scotland, UK; and
  2. †Specialist Virology Centre, Department of Laboratory Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK.
  1. Address correspondence and reprint requests to Mary Cairns, MBChB, Department of Gynaecological Oncology, Aberdeen Royal Infirmary, Scotland, UK AB25 2ZA. E-mail: marycairns{at}nhs.net.

Abstract

Objectives: Conservative management of women with microinvasive cervical cancer (International Federation of Gynecologists and Obstetricians stage IA) has led to prolonged and intensive cytological follow-up. We conducted a retrospective study to assess human papillomavirus status and genotypes at diagnosis and to find out whether there is an association between the persistence of high-risk human papillomavirus during follow-up and the detection of recurrent disease.

Study Design: Paraffin-embedded cervical biopsies in the pathology archives were identified from women with an initial large loop excision of the transformation zone or cone specimen diagnostic of microinvasive disease since 1991.

Results: We identified 45 women with a diagnosis of microinvasive cervical cancer. Human papillomavirus was detected in 87% of the initial diagnostic specimens. Human papillomavirus testing showed a negative predictive value of 100% for recurrent disease with a sensitivity of 100%.

Conclusion: Human papillomavirus testing has an important role in the follow-up of women treated conservatively for stage IA cervical cancer.

  • Human papillomavirus (HPV)
  • Microinvasive cervical cancer

http://dx.doi.org/10.1111/IGC.0b013e3181c3a6b6

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • This study was funded by Grampian NHS Endowments Fund.